𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast cancer after hodgkin's disease in two sisters

✍ Scribed by Frederick P. Li; Joseph Corkery; George Canellos; Harvey W. Neitlich


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
322 KB
Volume
47
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Two sisters had breast cancer at four years and I1 years after diagnosis of Hodgkin's disease. The affected breast tissues had received several hundred rads of scatter radiation during treatment of the lymphoma. Family history revealed breast cancer in a third sister and five other women in the paternal line. Cytogenetic and HLA studies showed no markers of susceptibility to neoplasia. Development of second primary neoplasms of the breast in the two sisters may have resulted from interactions between genetic factors and carcinogenic effects of radiation exposure. Cancer 47:200-202. 1981.

KENT STUDIES I N HUMANS suggest that genetic R factors can potentiate effects of environmental carcinogens.IJ This report examines host-environmental interactions in development of breast cancers in two sisters who previously had Hodgkin's disease treated with agents that possess carcinogenic properties.

Case Reports (Figure 1)

The proband developed right cervical adenopathy at 40 years of age in 1974. Biopsy revealed Hodgkin's disease. and laparotomy and other procedures revealed Stage IIA disease. Cobalt-60 radiotherapy was administered to the cervical, axillary, mediastinal, and retroperitoneal regions in doses between 3600 rads and 4400 rads to each area. The treatments produced transient erythema of the skin, mucositis, anorexia, and nausea. The patient has been in complete remission of Hodgkin's disease.

In February 1978, a 4 cm by 2 cm mass in the inferior subareolar region of the left breast developed in the patient. Histopathology examination of a biopsy specimen showed infiltrating ductal carcinoma. A modified radical mastectomy showed invasion of the lymphatics of the dermis of the nipple and metastatic carcinoma in two of nine axillary nodes. From available port films, the area of the left nipple had received between 200 rads and 600 rads during the therapy for Hodgkin's disease. Fibrocystic disease was also present in the breast tissue. She was treated with adjuvant chemotherapy and is in remission of breast cancer.


πŸ“œ SIMILAR VOLUMES


Intracranial Hodgkin's disease in two pa
✍ Ashigbi, Michael Y.; Venkatraj, Usha; Agarwal, Veneeta; Bello, Jackie; Wiernik, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 2 views

Intracranial Hodgkin's disease is very rare and is often a terminal event. The case of a 33-year-old man who relapsed in the anterior pituitary gland without other evidence of disease 6 months after extended field radiation therapy for Stage IIA Hodgkin's disease is presented. He remains well with n

Lung function after mantle field irradia
✍ Herman HΓΈst; Jon Rasmus Vale πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 English βš– 414 KB πŸ‘ 1 views

Seventeen patients with extrathoracic Hodgkin's disease were treated with mantle field irradiation and repeatedly observed with regard to their ventilatory function for 9-23 months after the completion of radiotherapy. Twelve of them also underwent thorough studies of pulmonary gas exchange. The vit

Bleomycin therapy in advanced Hodgkin's
✍ Michael B. Mosher; Ronald C. Deconti; Joseph R. Bertino πŸ“‚ Article πŸ“… 1972 πŸ› John Wiley and Sons 🌐 English βš– 457 KB πŸ‘ 2 views

Bleomycin was used to treat 31 patients with a variety of advanced, previously treated malignancies, with particular emphasis o n Hodgkin's disease and epidermoid cancers. Bleomycin was administered either twice weekly, 15 mg per dose, or in 5-day courses, 105 mg total dose per course. Three of 10 p